Status: current, Defined. Date: 31-Jul 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3422021000168110 | ascorbic acid + colloidal anhydrous silica + Vaccinium macrocarpon extract (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3422031000168113 | cranberry extract + colloidal anhydrous silica + ascorbic acid | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| cranberry extract + colloidal anhydrous silica + ascorbic acid | Is a | ascorbic acid + cranberry extract | true | Inferred relationship | Some | ||
| cranberry extract + colloidal anhydrous silica + ascorbic acid | has intended active ingredient | colloidal anhydrous silica | true | Inferred relationship | Some | 3 | |
| cranberry extract + colloidal anhydrous silica + ascorbic acid | has intended active ingredient | ascorbic acid | true | Inferred relationship | Some | 2 | |
| cranberry extract + colloidal anhydrous silica + ascorbic acid | has intended active ingredient | cranberry extract | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule | Is a | True | cranberry extract + colloidal anhydrous silica + ascorbic acid | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR